Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction

Plain-language summary

This study aims to discover new targets to reduce the risk of colorectal cancer and endometrial cancer. Adults aged 18 and older who have a hereditary cancer syndrome or who undergo endoscopy or gynecological screening can take part. It has no assigned phase and is currently recruiting participants.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Recruiting

Sponsor

Weill Medical College of Cornell University

Start date

5/29/2019

Estimated completion

12/31/2026

Countries

United States

Related genes

Locations

• New York, United States

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

The following eligibility criteria must be met as follows:

1. Age ≥ 18 years old.
2. One of the following must be met:

   1. Diagnosis of a Hereditary Cancer Syndrome by positive genetic testing and/or clinical criteria to undergo an endoscopy procedure (esophagoduodenoscopy and/or colonoscopy/flexible sigmoidoscopy), or endometrial screening procedure (transvaginal ultrasound and/or hysteroscopy and/or endometrial biopsy), OR
   2. Individuals coming to Weill-Cornell Medicine/NYPH to undergo an endoscopy procedure, transvaginal ultrasound, or hysteroscopy for average-risk (population-based) recommendation OR
   3. Individuals diagnosed with colorectal cancer or endometrial cancer coming to Weill- Cornell Medicine/NYPH for surgical treatment OR
   4. Individuals coming to Weill-Cornell Medicine/NYPH for care such as, but not limited to, diagnostic testing, clinic and/or treatment visit.
3. Willingness and ability to sign informed consent.
4. Ability to read/understand English, Spanish, and/or simplified Chinese.